Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10995091 CXCR4 receptor antagonists

Patent 10995091 was granted and assigned to Proximagen on May, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Proximagen

Current Assignee

Proximagen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

109950910

Patent Inventor Names

Alison Stewart0

Kathryn Oliver0

Lee Patient0

Michael Higginbottom0

Allison Carley0

Andrew Graham Cole0

Edward Daniel Savory0

Giles Brown0

...

Date of Patent

May 4, 2021

Patent Application Number

161670840

Date Filed

October 22, 2018

Patent Citations

‌

US Patent 10155761 CXCR4 receptor antagonists

Patent Citations Received

‌

US Patent 12083114 Inhibitors of SARM1 in combination with neuro-protective agents

Patent Primary Examiner

‌

Brenda L Coleman

Patent abstract

The compounds of formula (I) are antagonists of the CXCR4 receptor

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10995091 CXCR4 receptor antagonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API